FADS2 and lung cancer: HELLS is also known as LSH. Jiang et al. showed that high levels of LSH promoted the expression of lipid metabolism-related gene (GLUT1, SCD1 and FADS2), resulted in the reduction of intracellular lipid ROS, and then inhibited ferroptosis in lung cancer cells.